Customer Support: 800-526-4902
 

Fitzpatrick, Cella, Harper & Scinto

  - Office Profile
 





                  Firm Logo for Fitzpatrick Cella Harper Scinto
Fitzpatrick, Cella, Harper & Scinto 
New York, New York Office
View all offices

1290 Avenue of the Americas
New York, New York  10104-3800
(New York Co.)

Telephone: 212-218-2100
Facsimile: 212-218-2200
http://www.fitzpatrickcella.com

Profile Visibility
#40 in weekly profile views out of 8,638 law firms in New York, New York
#328 in weekly profile views out of 271,019 total law firms Overall



Intellectual Property LawPatent, Trademark, Copyright and Unfair Competition
 
               Learn More

 


About this office:

Fitzpatrick, Cella, Harper & Scinto has grown to about 175 attorneys practicing all areas of intellectual property law, including patents, trademarks, copyrights, unfair competition, and trade secrets. Our practice covers the spectrum of intellectual property services, including applying for patent and trademark protection, litigation, appeals, interferences, alternative dispute resolution, licensing, opinions, corporate transactions and due diligence. We have one of the premier patent litigation practices in the nation, and we also prosecute more than twice as many patents as any other New York-based firm.

Our offices in New York, Washington D.C. and Costa Mesa, California, serve a diverse national and international clientele from Fortune 500 companies to Internet start-ups. Founded in 1971, we have continually kept pace with the complex world of new technologies and the strategies required for protecting knowledge, vision and ideas.

The quality and experience of our attorneys is second to none. In addition to superior legal qualifications, the majority of our attorneys hold scientific degrees and many also have substantial industry experience. Our attorneys also have a long history of pro bono work, as well as active involvement in bar associations and community organizations.

Our clients do business in a wide range of industries including pharmaceuticals, chemicals, energy, biotechnology, computers, information technology, electronics, medical devices, transportation, telecommunications, finance, food and e-Commerce. As new technologies emerge, we work closely with our clients in developing strategies for protecting and enforcing their intellectual property.



 

Specific Practice & Industry Groups Details:
BiotechnologyCopyrights
E-Commerce & New MediaInterferences
Licensing & TransactionsLitigation
NanotechnologyPatent Prosecution
TrademarksUnfair Trade Practices


Statement of Practice Summary:
Litigation, Patent Prosecution, Trademarks, Copyrights, Licensing and Transactions. Unfair Trade Practices, Pharmaceuticals and Chemicals, Biotechnology. Electronics and Computers, e-Commerce and New Media, Nanotechnology, Interferences.



Documents by Lawyers at this office
Subscribe to this feed

Myriad Genetics: Supreme Court Holds That Isolated Human Genes are Unpatentable But cDNA is Patentable
Robert H. Fischer,Dennis Gregory,Dana Lau, June 14, 2013
On June 13, 2013 a unanimous United States Supreme Court held that the natural sequence of isolated human genes is a non-patentable product of nature. The Court also held that cDNA sequences—non-natural sequences—are patentable. Association for Molecular Pathology v. Myriad Genetics,...

CLS Bank v. Alice Corporation: En Banc Federal Circuit Finds Financial Services Patents Invalid Under 35 U.S.C. § 101 as Patent Ineligible
Josh Calabro,Robert H. Fischer,Douglas Sharrott, May 17, 2013
On May 10, 2013, a sharply divided en banc Federal Circuit held that computer-implemented methods, computer-readable media and computer systems for exchanging a financial obligation between parties do not recite patent-eligible subject matter under 35 U.S.C. § 101. Seven of the ten...

Supreme Court Hears Oral Argument in Myriad Genetics
Robert H. Fischer,Dennis Gregory,Dana Lau, April 18, 2013
The United States Supreme Court, on April 15, heard oral argument in Association for Molecular Pathology v. Myriad Genetics, No. 12-398. This case is to decide a profoundly important question, namely whether human genes are patent-eligible.




Year Established: 1971

Representative Clients:
American Express; Amgen; AstraZeneca; Astellas Pharma Inc.; Bausch & Lomb; Bear USA; Bristol-Myers Squibb; Canon Inc; Canon USA; The Clearing House; Conde Nast; Daiichi Sankyo; Eisai; Essilor International S.A.; Frederick Warne & Co., Inc.; Genzyme; GlaxoSmithKline; Honeywell; Hughes Network Systems; IBM; Instinet; Kyowa Hakko Kogyo; Medtronic; Merck; MTV Networks; Novartis; Phillips-Van Heusen; Prudential; Renkitt Benckiser; Rohde & Schwarz; Sanofi-Aventis; Schaeffler Technologies GmbH & Co. KG; S.C. Johnson & Son, Inc.; Sepracor; St. John's University; Tellabs Operations, Inc.; UCB Pharma, Inc.; Warner Chilcott.


Return to the Fitzpatrick, Cella, Harper & Scinto Firm Overview


 

Complete a Client Review


Have you recently worked with this firm? Share your experience as a Client of this firm and complete a Client Review to help others make an informed choice when hiring legal counsel.
 
 

Purchase Report

Buy an atVantage Firm Profile for insight into a law firm's litigation, bankruptcy, corporate transaction and patent prosecution experience.
 
 

Compare this Firm

Compare this firm to other firms in your Favorites.
 

Add firm to Favorites

As a registered user of martindale.com Connected, you can add firms to your list of Favorites. You can securely add comments and compare the firms in your Favorites.